David Garfield

David is global co-CEO and a member of the Board of Directors of AlixPartners. He has more than 30 years of deep industry experience as an executive and a consultant, working with board members and senior executives to develop winning strategies and accelerate growth in shareholder value. 

David is a member of the Board of Directors of the Ann & Robert H. Lurie Children’s Hospital of Chicago. He has served as an Advisory Board Member of Oxford University’s Enacting Purpose Initiative (“EPI”), a global group of leading members of large corporate Boards of Directors aimed at defining the role of “purpose” in corporate governance. David is also an Advisory Board Member of The Financial Times’ Outstanding Directors Exchange (“ODX”), where he advises The Financial Times on nominations and selections for Outstanding Directors of the Year. 

Previously, David served on the Board of Directors of Encore Corporation. David has been cited by CEO Magazine as a leading investment thinker and is a frequent contributor to media outlets including The Financial Times, The Economist, The Wall Street Journal, Bloomberg TV, National Public Radio, Fortune Magazine, and The New York Times, among others. He earned a BA in Psychology from Williams College and holds an MBA from Northwestern University's J.L. Kellogg Graduate School of Management, where he has also served as a guest lecturer to the Executive MBA program.